Related references
Note: Only part of the references are listed.Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor
Nicola Tumino et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses
Luis M. Franco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Glucocorticoids promote breast cancer metastasis
Milan M. S. Obradovic et al.
NATURE (2019)
Stress-elicited glucocorticoid receptor signaling upregulates TIGIT in innate like invariant T lymphocytes
Patrick T. Rudak et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma
Kamini Singh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
Silvia Pesce et al.
FRONTIERS IN IMMUNOLOGY (2019)
Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
Francesca Romana Merlotti et al.
FRONTIERS IN IMMUNOLOGY (2019)
Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids
Akihiro Tokunaga et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity
Heng Yang et al.
NATURE MEDICINE (2019)
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells
Natsumi Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Translation control of the immune checkpoint in cancer and its therapeutic targeting
Yichen Xu et al.
NATURE MEDICINE (2019)
Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board
Maria Cristina Mingari et al.
TRENDS IN IMMUNOLOGY (2019)
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression!
Francesca R. Mariotti et al.
ONCOIMMUNOLOGY (2019)
Molecular insight into targeting the NK cell immune response to cancer
Jai Rautela et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
Natural killers join the fight against cancer An antibody overcomes cancer cell immune evasion and activates natural killer cells
Adelheid Cerwenka et al.
SCIENCE (2018)
Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells
Linda Quatrini et al.
NATURE IMMUNOLOGY (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Neuroendocrine regulation of innate lymphoid cells
Linda Quatrini et al.
IMMUNOLOGICAL REVIEWS (2018)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Frank Stephen Hodi et al.
LANCET ONCOLOGY (2018)
Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma
Michael Cerezo et al.
NATURE MEDICINE (2018)
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
Silvia Pesce et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells
Linda Quatrini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid
D. Croxatto et al.
ONCOIMMUNOLOGY (2017)
Human CD56bright NK Cells: An Update
Tatiana Michel et al.
JOURNAL OF IMMUNOLOGY (2016)
Diversity and collaboration for effective immunotherapy
Karolina Palucka et al.
NATURE MEDICINE (2016)
Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer
Jennifer Chu et al.
TRENDS IN CELL BIOLOGY (2016)
New frontiers in translational control of the cancer genome
Morgan L. Truitt et al.
NATURE REVIEWS CANCER (2016)
Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy
Kailin Xing et al.
BMC IMMUNOLOGY (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation
Paola Vacca et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Taku Okazaki et al.
NATURE IMMUNOLOGY (2013)
The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2013)
Tumor Immunotherapy Directed at PD-1
Antoni Ribas
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses
Mariella Della Chiesa et al.
BLOOD (2006)
Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases
Ingrid Herr et al.
LANCET ONCOLOGY (2006)
Tumor microenvironment: What can effusions teach us?
J Kassis et al.
DIAGNOSTIC CYTOPATHOLOGY (2005)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Calcein-acetyoxymethyl cytotoxicity assay: Standardization of a method allowing additional analyses on recovered effector cells and supernatants
S Neri et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2001)
Share Paper
